These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1443 related articles for article (PubMed ID: 23207482)
1. Intravenous thrombolysis for acute ischemic stroke associated to extracranial internal carotid artery occlusion: the ICARO-2 study. Paciaroni M; Agnelli G; Caso V; Pieroni A; Bovi P; Cappellari M; Zini A; Nichelli P; Inzitari D; Nesi M; Nencini P; Pezzini A; Padovani A; Tassinari T; Orlandi G; Chiti A; Gialdini G; Alberti A; Venti M; Acciarresi M; D'Amore C; Luda E; Tassi R; Martini G; Ferrarese C; Beretta S; Trentini C; Silvestrelli G; Lanari A; Previdi P; Ciccone A; Delodovici ML; Bono G; Galletti G; Marcheselli S; Del Sette M; Traverso E; Riva M; Silvestrini M; Cerqua R; Consoli D; Monaco S; Toni D Cerebrovasc Dis; 2012; 34(5-6):430-5. PubMed ID: 23207482 [TBL] [Abstract][Full Text] [Related]
2. Renal impairment reduces the efficacy of thrombolytic therapy in acute ischemic stroke. Power A; Epstein D; Cohen D; Bathula R; Devine J; Kar A; Taube D; Duncan N; Ames D Cerebrovasc Dis; 2013; 35(1):45-52. PubMed ID: 23428996 [TBL] [Abstract][Full Text] [Related]
3. Early neurological deterioration within 24 hours after intravenous rt-PA therapy for stroke patients: the Stroke Acute Management with Urgent Risk Factor Assessment and Improvement rt-PA Registry. Mori M; Naganuma M; Okada Y; Hasegawa Y; Shiokawa Y; Nakagawara J; Furui E; Kimura K; Yamagami H; Kario K; Okuda S; Koga M; Minematsu K; Toyoda K Cerebrovasc Dis; 2012; 34(2):140-6. PubMed ID: 22854333 [TBL] [Abstract][Full Text] [Related]
4. Intravenous thrombolysis in young stroke patients: results from the SITS-ISTR. Toni D; Ahmed N; Anzini A; Lorenzano S; Brozman M; Kaste M; Mikulik R; Putaala J; Wahlgren N; Neurology; 2012 Mar; 78(12):880-7. PubMed ID: 22402853 [TBL] [Abstract][Full Text] [Related]
5. Systemic thrombolysis in patients with acute ischemic stroke and Internal Carotid ARtery Occlusion: the ICARO study. Paciaroni M; Balucani C; Agnelli G; Caso V; Silvestrelli G; Grotta JC; Demchuk AM; Sohn SI; Orlandi G; Leys D; Pezzini A; Alexandrov AV; Silvestrini M; Fofi L; Barlinn K; Inzitari D; Ferrarese C; Tassi R; Tsivgoulis G; Consoli D; Baldi A; Bovi P; Luda E; Galletti G; Invernizzi P; DeLodovici ML; Corea F; Del Sette M; Monaco S; Marcheselli S; Alberti A; Venti M; Acciarresi M; D'Amore C; Macellari F; Lanari A; Previdi P; Gonzales NR; Pandurengan RK; Vahidy FS; Sline M; Bal SS; Chiti A; Gialdini G; Dumont F; Cordonnier C; Debette S; Padovani A; Cerqua R; Bodechtel U; Kepplinger J; Nesi M; Nencini P; Beretta S; Trentini C; Martini G; Piperidou C; Heliopoulos I; D'Anna S; Cappellari M; Donati E; Bono G; Traverso E; Toni D Stroke; 2012 Jan; 43(1):125-30. PubMed ID: 22034003 [TBL] [Abstract][Full Text] [Related]
6. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator. Chung JW; Kim KJ; Noh WY; Jang MS; Yang MH; Han MK; Kwon OK; Jung C; Kim JH; Oh CW; Lee JS; Lee J; Bae HJ Cerebrovasc Dis; 2013; 35(5):461-8. PubMed ID: 23735898 [TBL] [Abstract][Full Text] [Related]
7. Symptomatic intracranial hemorrhage following intravenous thrombolysis for acute ischemic stroke: a critical review of case definitions. Seet RC; Rabinstein AA Cerebrovasc Dis; 2012; 34(2):106-14. PubMed ID: 22868870 [TBL] [Abstract][Full Text] [Related]
8. Results of intravenous thrombolysis within 4.5 to 6 hours and updated results within 3 to 4.5 hours of onset of acute ischemic stroke recorded in the Safe Implementation of Treatment in Stroke International Stroke Thrombolysis Register (SITS-ISTR): an observational study. Ahmed N; Kellert L; Lees KR; Mikulik R; Tatlisumak T; Toni D; JAMA Neurol; 2013 Jul; 70(7):837-44. PubMed ID: 23689267 [TBL] [Abstract][Full Text] [Related]
18. Intravenous alteplase at 0.6 mg/kg for acute stroke patients with basilar artery occlusion: the stroke acute management with urgent risk factor assessment and improvement (SAMURAI) Recombinant tissue plasminogen activator registry. Miyagi T; Koga M; Shiokawa Y; Nakagawara J; Hasegawa Y; Furui E; Kimura K; Kario K; Okuda S; Yamagami H; Okada Y; Nezu T; Maeda K; Endo K; Minematsu K; Toyoda K J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):1098-106. PubMed ID: 23063059 [TBL] [Abstract][Full Text] [Related]
19. Safety and effectiveness of endovascular treatment after 6 hours of symptom onset in patients with anterior circulation ischemic stroke: a matched case control study. Qureshi AI; Miley JT; Chaudhry SA; Semaan E; Rodriguez GJ; Suri MF; Adams HP J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):1076-81. PubMed ID: 23099041 [TBL] [Abstract][Full Text] [Related]
20. Intravenous recombinant tissue plasminogen activator for acute stroke in Poland: an analysis based on the Safe Implementation of Thrombolysis in Stroke (SITS) Registry. Kobayashi A; Czlonkowska A; Ahmed N; Romanowicz S; Glonek M; Nyka WM; Opala G; Wahlgren N; Acta Neurol Scand; 2010 Oct; 122(4):229-36. PubMed ID: 19919643 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]